STK11/LKB1 genomic alterations are associated with inferior clinical outcomes with chemo-immunotherapy in non-squamous NSCLC Meeting Abstract


Authors: Skoulidis, F.; Arbour, K.; Hellmann, M.; Patil, P.; Marmarelis, M.; Owen, D.; Awad, M.; Murray, J.; Levy, B.; Hellyer, J.; Gainor, J.; Stewart, T.; Goldberg, S.; Dimou, A.; Bestvina, C.; Cummings, A.; Elamin, Y.; Lam, V.; Zhang, J.; Shu, C.; Riess, J.; Blakely, C.; Pecot, C.; Mezquita, L.; Tabbo, F.; Sacher, A.; Scheffler, M.; Ricciuti, B.; Venkatraman, D.; Rizvi, H.; Liu, C.; Johnston, R.; Ni, Y.; Azok, J.; Kier, M.; Katz, S.; Davies, K.; Segal, J.; Ritterhouse, L.; Shaish, H.; Lacroix, L.; Memmott, R.; Madrigal, J.; Goldman, J.; Lau, S.; Killam, J.; Walther, Z.; Carter, B.; Woodcock, M.; Roth, J.; Swisher, S.; Leighl, N.; Digumarthy, S.; Mooradian, M.; Rotow, J.; Wolf, J.; Scagliotti, G.; Planchard, D.; Besse, B.; Bivona, T.; Gandara, D.; Garon, E.; Rizvi, N.; Camidge, D. R.; Schalper, K.; Herbst, R.; Shaw, A.; Neal, J.; Wakelee, H.; Brahmer, J.; Janne, P.; Carbone, D.; Aggarwal, C.; Pennell, N.; Rudin, C.; Papadimitrakopoulou, V.; Heymach, J.
Abstract Title: STK11/LKB1 genomic alterations are associated with inferior clinical outcomes with chemo-immunotherapy in non-squamous NSCLC
Meeting Title: 20th World Conference on Lung Cancer of the International Association for the Study of Lung Cancer (IASLC)
Keywords: pembrolizumab; chemo-immunotherapy; stk11/lkb1
Journal Title: Journal of Thoracic Oncology
Volume: 14
Issue: 10 Suppl.
Meeting Dates: 2019 Sept 7-10
Meeting Location: Barcelona, Spain
ISSN: 1556-0864
Publisher: Elsevier Inc.  
Date Published: 2019-10-01
Start Page: S294
End Page: S295
Language: English
ACCESSION: WOS:000492162201276
DOI: 10.1016/j.jtho.2019.08.591
PROVIDER: wos
Notes: Meeting Abstract: MA11.11 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    411 Hellmann
  2. Charles Rudin
    488 Rudin
  3. Kathryn Cecilia Arbour
    88 Arbour
  4. Hira Abbas Rizvi
    122 Rizvi